Amersham, United Kingdom

Duncan George Wynn

USPTO Granted Patents = 12 

 

Average Co-Inventor Count = 3.4

ph-index = 2

Forward Citations = 12(Granted Patents)


Location History:

  • Amersham, GB (2011 - 2019)
  • Buckinghamshire, GB (2012 - 2023)

Company Filing History:


Years Active: 2011-2023

Loading Chart...
Loading Chart...
12 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Duncan George Wynn

Introduction

Duncan George Wynn is a notable inventor based in Amersham, GB, recognized for his significant contributions to the field of medical imaging and radiopharmaceuticals. With a total of 12 patents to his name, Wynn has developed innovative solutions that enhance user safety and flexibility in medical procedures.

Latest Patents

Among his latest patents is the "Tailored Dose of Contrast Agent," which discloses novel procedures, systems, and excipient solutions for the in situ provision of contrast media at user-defined concentrations. This automated procedure enhances user safety, flexibility, and user-friendliness. Another significant invention is the "Radiolabelling Method," which pertains to automated methods for the preparation and purification of F-labelled tau imaging radiotracers, including interchangeable cassettes useful in these methods.

Career Highlights

Wynn has worked with prominent companies such as GE Healthcare AS and GE Healthcare Limited, where he has applied his expertise to advance medical technologies. His work has had a profound impact on the field, particularly in improving imaging techniques and patient safety.

Collaborations

Throughout his career, Duncan George Wynn has collaborated with esteemed colleagues, including Ian M Newington and Alan Cuthbertson, contributing to the development of innovative solutions in his field.

Conclusion

Duncan George Wynn's contributions to medical imaging and radiopharmaceuticals exemplify the spirit of innovation. His patents and collaborations reflect a commitment to enhancing healthcare technologies and improving patient outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…